# Single-arm Study to Assess the Safety of Hydromorphone Hydrochloride by Intrathecal Administration

> **NCT01709747** · PHASE3 · COMPLETED · sponsor: **Piramal Critical Care, Ltd.** · enrollment: 364 (actual)

## Conditions studied

- Chronic Pain

## Interventions

- **DRUG:** Hydromorphone Hydrochloride
- **DEVICE:** Programmable Implantable pump

## Key facts

- **NCT ID:** NCT01709747
- **Lead sponsor:** Piramal Critical Care, Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2018-02
- **Final completion:** 2018-02
- **Target enrollment:** 364 (ACTUAL)
- **Last updated:** 2021-08-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01709747

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01709747, "Single-arm Study to Assess the Safety of Hydromorphone Hydrochloride by Intrathecal Administration". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01709747. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*